Multifunctional microbeads for drug delivery in TACE

被引:34
作者
Bannerman, Dawn [1 ]
Wan, Wankei [1 ,2 ]
机构
[1] Univ Western Ontario, Grad Program Biomed Engn, London, ON, Canada
[2] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Drug-eluting beads; imaging; localized delivery; multifunctional; nano-onmicro; transarterial chemoembolization; DEGRADABLE STARCH MICROSPHERES; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION; DOXORUBICIN-ELUTING BEADS; RABBIT LIVER-TUMOR; DC BEAD; POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES; EMBOLIZATION HYPERTHERMIA; CHITOSAN MICROSPHERES;
D O I
10.1080/17425247.2016.1192122
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Transarterial chemoembolization (TACE) is the standard treatment for unresectable intermediate-stage hepatocellular carcinoma (HCC). Microbeads used to embolize tumor vasculature have recently been designed to deliver a therapeutic drug to the tumor site. Increasing the functionality of microbeads for TACE has the potential to improve therapy by accomplishing multiple, beneficial tasks with one system. Areas covered: Microbead functions beyond embolization and drug delivery that could be highly advantageous include detection and tracking with imaging, targeting, degradation, and the delivery of multiple therapeutics or combination therapies. This review covers the concepts of TACE for treatment of HCC, the need for controlled delivery systems and the use of drug-eluting beads. Shortcomings of the current technology and the current approaches to improve materials used as embolic microbeads are discussed. Relevant studies aimed to enhance microbead visibility, targetability, degradability, and the use of multiple therapeutics or combination therapies are reviewed. Expert opinion: The incorporation of nanoparticles that possess desirable properties into the microbead matrix is a suitable method of creating multifunctional microbeads. The development of these 'nano-on-micro' systems is a promising approach to improve TACE therapy and may lead to improved treatment.
引用
收藏
页码:1289 / 1300
页数:12
相关论文
共 110 条
[21]   A Novel Inherently Radiopaque Bead for Transarterial Embolization to Treat Liver Cancer - A Pre-clinical Study [J].
Duran, Rafael ;
Sharma, Karun ;
Dreher, Matthew R. ;
Ashrafi, Koorosh ;
Mirpour, Sahar ;
Lin, MingDe ;
Schernthaner, Ruediger E. ;
Schlachter, Todd R. ;
Tacher, Vania ;
Lewis, Andrew L. ;
Willis, Sean ;
den Hartog, Mark ;
Radaelli, Alessandro ;
Negussie, Ayele H. ;
Wood, Bradford J. ;
Geschwind, Jean-Francois H. .
THERANOSTICS, 2016, 6 (01) :28-39
[22]   BLOCKAGE OF THE HEPATIC-ARTERY BLOOD-FLOW BY BIODEGRADABLE MICROSPHERES (SPHEREX) COMBINED WITH LOCAL HYPERTHERMIA IN THE TREATMENT OF EXPERIMENTAL LIVER-TUMORS IN RATS [J].
ERICHSEN, C ;
BOLMSJO, M ;
HUGANDER, A ;
JONSSON, PE .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1985, 109 (01) :38-41
[23]  
European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI [10.1016/j.ejca.2011.12.021, 10.1016/j.jhep.2011.12.001]
[24]   Development of a combination drug-eluting bead: towards enhanced efficacy for locoregional tumour therapies [J].
Forster, Richard E. J. ;
Tang, Yiqing ;
Bowyer, Cressida ;
Lloyd, Andrew W. ;
Macfarlane, Wendy ;
Phillips, Gary J. ;
Lewis, Andrew L. .
ANTI-CANCER DRUGS, 2012, 23 (04) :355-369
[25]   Polymer microspheres for controlled drug release [J].
Freiberg, S ;
Zhu, X .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 282 (1-2) :1-18
[26]   Sunitinib-eluting beads for chemoembolization: Methods for in vitro evaluation of drug release [J].
Fuchs, Katrin ;
Bize, Pierre E. ;
Denys, Alban ;
Borchard, Gerrit ;
Jordan, Olivier .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 482 (1-2) :68-74
[27]   Drug-Eluting Beads Loaded with Antiangiogenic Agents for Chemoembolization: In Vitro Sunitinib Loading and Release and In Vivo Pharmacokinetics in an Animal Model [J].
Fuchs, Katrin ;
Bize, Pierre E. ;
Dormond, Olivier ;
Denys, Alban ;
Doelker, Eric ;
Borchard, Gerrit ;
Jordan, Olivier .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2014, 25 (03) :379-387
[28]   Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma [J].
Furuse, J ;
Ishii, H ;
Satake, M ;
Onaya, H ;
Nose, H ;
Mikami, S ;
Sakai, H ;
Mera, K ;
Maru, Y ;
Yoshino, M .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (02) :159-164
[29]   Hepatocellular carcinoma with portal vein tumor thrombus: Embolization of arterioportal shunts [J].
Furuse, J ;
Iwasaki, M ;
Yoshino, M ;
Konishi, M ;
Kawano, N ;
Kinoshita, T ;
Ryu, M ;
Satake, M ;
Moriyama, N .
RADIOLOGY, 1997, 204 (03) :787-790
[30]   Transarterial chemoembolization of hepatocellular carcinoma - agents and drugs: an overview. Part 2 [J].
Giunchedi, Paolo ;
Maestri, Marcello ;
Gavini, Elisabetta ;
Dionigi, Paolo ;
Rassu, Giovanna .
EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (06) :799-810